AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Savara Inc Director's Dealing 2015

Jun 12, 2015

32709_dirs_2015-06-12_3e90f751-b6b0-4235-a4ac-cc8dc9d28722.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mast Therapeutics, Inc. (MSTX)
CIK: 0001160308
Period of Report: 2015-06-11

Reporting Person: RAMSAY DAVID A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-11	Stock Option (Right to Buy)	$0.50	A	82963	Acquired	2025-06-11	Common Stock (82963)	Direct

Footnotes

F1: This option vests and becomes exercisable in 12 substantially equal monthly installments on each monthly anniversary of June 11, 2015, subject to the reporting person's continued service with the issuer.